Announcement
08 Jan 2026
In January 2026, Johnson & Johnson announced reaching an agreement with the United States government to implement most-favoured-nation drug pricing for American patients.
Source
Number of interventions
3
0 certainly harmful
3 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
Recent update from 05 Apr 2026:
Recent update from 05 Apr 2026:
Recent update from 05 Apr 2026:
See all
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
2
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70711
194